دورية أكاديمية

Epidemiology of acute infections in people who inject drugs in Australia.

التفاصيل البيبلوغرافية
العنوان: Epidemiology of acute infections in people who inject drugs in Australia.
المؤلفون: Attwood LO; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia., O'Keefe D; Burnet Institute, Melbourne, Australia., Higgs P; Burnet Institute, Melbourne, Australia.; Department of Public Health, La Trobe University, Melbourne, Australia., Vujovic O; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia., Doyle JS; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.; Burnet Institute, Melbourne, Australia., Stewardson AJ; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
المصدر: Drug and alcohol review [Drug Alcohol Rev] 2024 Jan; Vol. 43 (1), pp. 304-314. Date of Electronic Publication: 2023 Nov 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: Australia NLM ID: 9015440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1465-3362 (Electronic) Linking ISSN: 09595236 NLM ISO Abbreviation: Drug Alcohol Rev Subsets: MEDLINE
أسماء مطبوعة: Publication: Original Publication: Abingdon, Oxfordshire, U.K. : Carfax Pub. Co.,
مواضيع طبية MeSH: Substance Abuse, Intravenous*/epidemiology , Substance Abuse, Intravenous*/complications , Soft Tissue Infections*/complications , Soft Tissue Infections*/epidemiology , Drug Users*/psychology, Humans ; Risk Factors ; Australia/epidemiology
مستخلص: Issues: People who inject drugs are at risk of acute infections, such as skin and soft tissue infections, infective endocarditis, bone and joint infections and bloodstream infections. There has been an increase in these infections in people who inject drugs internationally over the past 10 years. However, the local data regarding acute infections in Australia has not been well described.
Approach: We review the epidemiology of acute infections and associated morbidity and mortality amongst people who inject drugs in Australia. We summarise risk factors for these infections, including the concurrent social and psychological determinants of health.
Key Findings: The proportion of people who report having injected drugs in the prior 12 months in Australia has decreased over the past 18 years. However, there has been an increase in the burden of acute infections in this population. This increase is driven largely by skin and soft tissue infections. People who inject drugs often have multiple conflicting priorities that can delay engagement in care.
Implications: Acute infections in people who inject drugs are associated with significant morbidity and mortality. Acute infections contribute to significant bed days, surgical requirements and health-care costs in Australia. The increase in these infections is likely due to a complex interplay of microbiological, individual, social and environmental factors.
Conclusion: Acute infections in people who inject drugs in Australia represent a significant burden to both patients and health-care systems. Flexible health-care models, such as low-threshold wound clinics, would help directly target, and address early interventions, for these infections.
(© 2023 The Authors. Drug and Alcohol Review published by John Wiley & Sons Australia, Ltd on behalf of Australasian Professional Society on Alcohol and other Drugs.)
References: Clin Infect Dis. 2019 Sep 13;69(7):1120-1129. (PMID: 30590480)
PLoS One. 2020 Nov 9;15(11):e0242165. (PMID: 33166363)
Drug Alcohol Rev. 2024 Jan;43(1):304-314. (PMID: 37995135)
Int J Drug Policy. 2019 Mar;65:24-30. (PMID: 30590304)
PLoS One. 2020 Apr 24;15(4):e0232191. (PMID: 32330184)
S Afr Med J. 2018 Jun 26;108(7):585-589. (PMID: 30004347)
Emerg Infect Dis. 2017 Aug;23(8):1400-1403. (PMID: 28726606)
Int J Drug Policy. 2020 Sep;83:102837. (PMID: 32645585)
Drug Alcohol Depend. 2019 Apr 1;197:108-114. (PMID: 30802734)
BMC Public Health. 2017 Sep 29;17(1):757. (PMID: 28962604)
Open Forum Infect Dis. 2020 Sep 09;7(10):ofaa414. (PMID: 33094117)
Drug Alcohol Rev. 2020 Nov;39(7):932-940. (PMID: 32666650)
PLoS One. 2019 Nov 26;14(11):e0225460. (PMID: 31770395)
J Gen Intern Med. 2021 Jan;36(1):129-137. (PMID: 32918199)
Harm Reduct J. 2021 Feb 17;18(1):20. (PMID: 33596940)
Clin Infect Dis. 2023 Aug 14;77(3):338-345. (PMID: 36916065)
Subst Use Misuse. 2018 Feb 23;53(3):457-465. (PMID: 29035611)
Intern Med J. 2020 Oct;50(10):1240-1246. (PMID: 31841254)
Drug Alcohol Depend. 2020 Aug 1;213:108080. (PMID: 32526658)
J Addict Med. 2022 Jul-Aug 01;16(4):433-439. (PMID: 34711742)
Lancet. 2012 Jan 7;379(9810):55-70. (PMID: 22225671)
Intern Med J. 2022 Oct;52(10):1741-1748. (PMID: 34028966)
Clin Infect Dis. 2021 Jul 1;73(1):e69-e78. (PMID: 32421194)
Drug Alcohol Depend. 2021 Apr 1;221:108646. (PMID: 33677353)
Am J Public Health. 2015 Dec;105(12):e53-9. (PMID: 26469651)
Epidemiol Infect. 2015 Jan;143(1):120-31. (PMID: 24568684)
Interdiscip Perspect Infect Dis. 2022 Dec 16;2022:6484960. (PMID: 36570593)
Harm Reduct J. 2022 Sep 7;19(1):101. (PMID: 36071500)
Harm Reduct J. 2019 Dec 12;16(1):69. (PMID: 31831010)
J Infect. 2019 Nov;79(5):435-443. (PMID: 31419474)
Emerg Infect Dis. 2020 Mar;26(3):. (PMID: 32091385)
Int J Drug Policy. 2018 Jul;57:104-110. (PMID: 29715589)
Drug Alcohol Depend. 2013 Oct 1;132(3):541-6. (PMID: 23664499)
Int J Drug Policy. 2020 Oct;84:102866. (PMID: 32712484)
J Am Coll Cardiol. 2019 Feb 12;73(5):559-570. (PMID: 30732709)
Ann Thorac Surg. 2015 Sep;100(3):875-82. (PMID: 26095108)
Harm Reduct J. 2021 Feb 16;18(1):19. (PMID: 33593364)
Harm Reduct J. 2017 Jun 5;14(1):32. (PMID: 28583121)
Soc Sci Med. 2014 Mar;105:59-66. (PMID: 24508718)
Int J Infect Dis. 2021 Nov;112:63-65. (PMID: 34520844)
Drug Alcohol Depend. 2017 Feb 01;171:39-49. (PMID: 28013096)
BMC Infect Dis. 2018 Oct 24;18(1):532. (PMID: 30355291)
Clin Infect Dis. 2021 Dec 6;73(11):e3661-e3669. (PMID: 32901815)
Drug Alcohol Depend. 2020 Nov 1;216:108267. (PMID: 32916518)
Indian Heart J. 2021 Nov-Dec;73(6):711-717. (PMID: 34861981)
Drug Alcohol Depend. 2022 Jul 1;236:109494. (PMID: 35605532)
Int J Drug Policy. 2009 Jul;20(4):340-6. (PMID: 18835767)
APMIS. 2023 Jun;131(6):294-302. (PMID: 37026991)
Drug Alcohol Rev. 2022 Nov;41(7):1543-1553. (PMID: 36053863)
Aust N Z J Public Health. 2009 Aug;33(4):352-7. (PMID: 19689596)
Health Aff (Millwood). 2016 May 1;35(5):832-7. (PMID: 27140989)
Aust N Z J Public Health. 2015 Apr;39(2):182-7. (PMID: 25827187)
Drug Alcohol Depend. 2020 Jul 1;212:108057. (PMID: 32422537)
Clin Infect Dis. 2020 Jul 27;71(3):564-571. (PMID: 31504326)
Eur Heart J. 2010 Aug;31(15):1890-7. (PMID: 20453066)
Harm Reduct J. 2020 Jul 31;17(1):53. (PMID: 32736624)
J Infect. 2013 Jan;66(1):95-102. (PMID: 23068454)
Heart Lung Circ. 2018 Apr;27(4):484-488. (PMID: 28533098)
Harm Reduct J. 2019 Feb 13;16(1):16. (PMID: 30760261)
J Am Coll Cardiol. 2018 Apr 10;71(14):1596-1597. (PMID: 29622169)
Euro Surveill. 2019 Mar;24(13):. (PMID: 30940316)
BMJ. 2022 Oct 7;379:e072635. (PMID: 36207027)
Open Forum Infect Dis. 2022 Jan 06;9(2):ofab631. (PMID: 35097153)
J Infect Dis. 2020 Sep 2;222(Suppl 5):S458-S464. (PMID: 32877536)
Heart Lung Circ. 2020 Feb;29(2):246-253. (PMID: 30962062)
J Urban Health. 2019 Oct;96(5):734-740. (PMID: 31493182)
Ann Intern Med. 2019 Jan 1;170(1):31-40. (PMID: 30508432)
BMJ Open. 2023 Apr 3;13(4):e070236. (PMID: 37012020)
Open Forum Infect Dis. 2016 Jul 26;3(3):ofw157. (PMID: 27800528)
Drug Alcohol Rev. 2017 Mar;36(2):160-170. (PMID: 27286742)
Int J Drug Policy. 2017 Apr;42:1-6. (PMID: 28104570)
J Behav Health Serv Res. 2010 Oct;37(4):508-18. (PMID: 19381818)
Int J Drug Policy. 2022 May;103:103655. (PMID: 35349964)
Clin Infect Dis. 2001 Feb 15;32(4):581-6. (PMID: 11181121)
Arch Surg. 2002 Nov;137(11):1217-22. (PMID: 12413304)
Eur Heart J. 2015 Nov 21;36(44):3075-3128. (PMID: 26320109)
Drug Alcohol Depend. 2018 Sep 1;190:188-194. (PMID: 30048872)
Drug Alcohol Depend. 2020 Feb 1;207:107793. (PMID: 31874449)
Int J Drug Policy. 2021 Oct;96:103319. (PMID: 34154905)
Clin Infect Dis. 2020 Oct 23;71(7):e37-e44. (PMID: 31907515)
Drug Alcohol Rev. 2022 Jul;41(5):1053-1061. (PMID: 35411617)
J Infect Dis. 2020 Sep 2;222(Suppl 5):S429-S436. (PMID: 32877563)
Addiction. 2021 Jul;116(7):1914-1924. (PMID: 33051902)
Am J Med. 2012 Jun;125(6):594-602. (PMID: 22513194)
Ann Thorac Surg. 2020 May;109(5):1426-1432. (PMID: 31630767)
Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. (PMID: 29074409)
J Addict Dis. 2020 Oct-Dec;38(4):420-437. (PMID: 32633640)
Am Fam Physician. 2019 Jan 15;99(2):109-116. (PMID: 30633481)
Drug Alcohol Depend. 2022 Aug 1;237:109543. (PMID: 35772249)
Clin Infect Dis. 2021 May 18;72(10):1782-1783. (PMID: 32270858)
Drug Alcohol Depend. 2009 Apr 1;101(1-2):132-6. (PMID: 19167171)
J Addict Med. 2020 Jul/Aug;14(4):282-286. (PMID: 31634202)
Clin Infect Dis. 2019 Mar 19;68(7):1166-1175. (PMID: 30215683)
Drug Alcohol Depend. 2009 Feb 1;100(1-2):9-16. (PMID: 19013725)
Open Forum Infect Dis. 2021 May 29;8(6):ofab285. (PMID: 34189180)
PLoS Med. 2022 Jul 19;19(7):e1004049. (PMID: 35853024)
Drug Alcohol Rev. 2022 Sep;41(6):1304-1310. (PMID: 35266229)
معلومات مُعتمدة: GNT1141398 National Health and Medical Research Council; GNT1166499 National Health and Medical Research Council; GNT2002670 National Health and Medical Research Council
فهرسة مساهمة: Keywords: epidemiology; health systems; injecting drug use; sepsis; skin and soft tissue infections
تواريخ الأحداث: Date Created: 20231123 Date Completed: 20240131 Latest Revision: 20240322
رمز التحديث: 20240322
مُعرف محوري في PubMed: PMC10952783
DOI: 10.1111/dar.13772
PMID: 37995135
قاعدة البيانات: MEDLINE
الوصف
تدمد:1465-3362
DOI:10.1111/dar.13772